The independent privacy layer for AI.
AI runs on real-world data. The bottleneck was never just compute. It was moving regulated data into pipelines without taking on privacy risk. Integral assesses, engineers, and documents that data so it moves at AI speed and holds up under examination.
Trusted by healthcare and data teams
How we make regulated data move at AI speed
Risk assessment
Qualified statistical experts assess re-identification risk, scope the engagement, and produce documentation calibrated to the domain. Expert Determination for HIPAA; equivalent independent assessments for other regulated data.
Signal-preserving engineering
Privacy remediation tuned to keep the analytical and training value that makes the data worth using. Utility measured, not assumed.
Continuous re-assessment
Datasets change. Recipients change. Re-assessment keeps the posture current and the documentation audit-ready as data moves downstream.
Purpose-built for regulated data
Every capability is designed around the reality of working with sensitive healthcare data at scale.
Real-world data, de-identified upstream
Integral assesses re-identification risk through qualified Expert Determination, engineers privacy remediation that preserves analytical value, and documents every decision for downstream examination.
Defensible privacy assessments
Signed, scoped opinions from qualified statistical experts grounded in HIPAA methodology. The highest standard of defensibility.
Qualified expert sign-off
Every determination is supported by a qualified expert who signs off on the methodology and results. Examination-ready from day one.
Documentation that travels with data
Audit-ready documentation, monitoring timeline, and field-level retention tracking. Every decision logged and traceable.
Analytical value retained after privacy remediation — measured, not assumed.
From data intake to signed risk assessment opinion.
Entities assessed and remediated across client datasets.
What teams say
“Before Integral, compliance projects were a limiting factor. It would take months to get one done, and we still couldn't explain why certain decisions were made. Integral's approach is notably more creative and scalable than any other solution. Their operations process is very clean, which builds confidence with our clients. And by automating most of the process, Integral has cut our timelines in half. That speed has made a huge difference for us.”
“We wanted a solution that would allow us to massage the data sets we were already using and augment them over time - without requiring a from-scratch re-analysis of the overarching data set. Today, all our data sources go through Integral before they ever hit an environment we access. Without Integral's flexibility, we couldn't stay compliant as data shifts.”
“Integral goes beyond the initial report. They peel back the layers and keep asking the right questions until they truly understand how your data works. That level of attention is what you need when pharma clients are asking hard questions and expect real answers.”
“It felt like a true collaboration. Integral was responsive, detail-oriented, and genuinely invested in getting it right. That kind of partnership is rare, and it is exactly what we needed to move with confidence.”
